Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Achieving the Lowest Effective Antipsychotic Dose for Patients with Remitted Psychosis: A Proposed Guided Dose-Reduction Algorithm
Authors
Keywords
-
Journal
CNS DRUGS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-11-18
DOI
10.1007/s40263-019-00682-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 20-Year Nationwide Follow-Up Study on Discontinuation of Antipsychotic Treatment in First-Episode Schizophrenia
- (2018) Jari Tiihonen et al. AMERICAN JOURNAL OF PSYCHIATRY
- Trajectories after first-episode psychosis: Complement to ambiguous outcomes of long-term antipsychotic treatment by exploring a few hidden cases
- (2018) Chen-Chung Liu et al. Early Intervention in Psychiatry
- Dose reduction of risperidone and olanzapine can improve cognitive function and negative symptoms in stable schizophrenic patients: A single-blinded, 52-week, randomized controlled study
- (2018) Yanling Zhou et al. JOURNAL OF PSYCHOPHARMACOLOGY
- F121. DOES RELAPSE CONTRIBUTE TO TREATMENT RESISTANCE? ANTIPSYCHOTIC RESPONSE IN FIRST- VS. SECOND-EPISODE SCHIZOPHRENIA
- (2018) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA BULLETIN
- Increasing expectations and knowledge require a more subtle use of prophylactic antipsychotics
- (2018) Robin M. Murray et al. World Psychiatry
- “Will I need to take these medications for the rest of my life?”
- (2018) Stephen R. Marder et al. World Psychiatry
- Long-term antipsychotic treatment of schizophrenia: does it help or hurt over a 20-year period?
- (2018) Martin Harrow et al. World Psychiatry
- Is there compelling evidence that schizophrenia long-term treatment guidelines should be changed?
- (2018) Stefan Leucht World Psychiatry
- Antipsychotic maintenance treatment in schizophrenia and the importance of preventing relapse
- (2018) Robin Emsley World Psychiatry
- Under-utilized opportunities to optimize medication management in long-term treatment of schizophrenia
- (2018) Matti Isohanni et al. World Psychiatry
- What is the risk-benefit ratio of long-term antipsychotic treatment in people with schizophrenia?
- (2018) Christoph U. Correll et al. World Psychiatry
- The long-term treatment of schizophrenia with antipsychotics: a perennial debate
- (2018) W. Wolfgang Fleischhacker World Psychiatry
- Can antipsychotic dose reduction lead to better functional recovery in first-episode psychosis? A randomized controlled-trial of antipsychotic dose reduction. The reduce trial: Study protocol
- (2018) Amber Weller et al. Early Intervention in Psychiatry
- A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia
- (2017) Martin Harrow et al. PSYCHIATRY RESEARCH
- Antipsychotic-Induced Dopamine Supersensitivity Psychosis: Pharmacology, Criteria, and Therapy
- (2017) Guy Chouinard et al. PSYCHOTHERAPY AND PSYCHOSOMATICS
- Antipsychotic medication and remission of psychotic symptoms 10 years after a first-episode psychosis
- (2017) Regitze Sølling Wils et al. SCHIZOPHRENIA RESEARCH
- TAILOR – tapered discontinuation versus maintenance therapy of antipsychotic medication in patients with newly diagnosed schizophrenia or persistent delusional disorder in remission of psychotic symptoms: study protocol for a randomized clinical trial
- (2017) Anne Emilie Stürup et al. Trials
- Clinical and demographic predictors of continuing remission or relapse following discontinuation of antipsychotic medication after a first episode of psychosis. A systematic review
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Rates and predictors of relapse following discontinuation of antipsychotic medication after a first episode of psychosis
- (2017) Meghan Bowtell et al. SCHIZOPHRENIA RESEARCH
- Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders
- (2016) Cherrie Galletly et al. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY
- Beyond Clinical Remission in First Episode Psychosis: Thoughts on Antipsychotic Maintenance vs. Guided Discontinuation in the Functional Recovery Era
- (2016) M. Alvarez-Jimenez et al. CNS DRUGS
- Therapeutic improvements expected in the near future for schizophrenia and schizoaffective disorder: an appraisal of phase III clinical trials of schizophrenia-targeted therapies as found in US and EU clinical trial registries
- (2016) Ricardo P. Garay et al. EXPERT OPINION ON PHARMACOTHERAPY
- Altering the course of schizophrenia: progress and perspectives
- (2016) Mark J. Millan et al. NATURE REVIEWS DRUG DISCOVERY
- The Effect of Antipsychotic Treatment on Cortical Gray Matter Changes in Schizophrenia: Does the Class Matter? A Meta-analysis and Meta-regression of Longitudinal Magnetic Resonance Imaging Studies
- (2015) Antonio Vita et al. BIOLOGICAL PSYCHIATRY
- The Use of Continuous Treatment Versus Placebo or Intermittent Treatment Strategies in Stabilized Patients with Schizophrenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials with First- and Second-Generation Antipsychotics
- (2015) Marc De Hert et al. CNS DRUGS
- Views of early psychosis clinicians on discontinuation of antipsychotic medication following symptom remission in first episode psychosis
- (2015) Andrew Thompson et al. Early Intervention in Psychiatry
- Clinical Outcome After Antipsychotic Treatment Discontinuation in Functionally Recovered First-Episode Nonaffective Psychosis Individuals
- (2015) Jacqueline Mayoral-van Son et al. JOURNAL OF CLINICAL PSYCHIATRY
- Challenging the need for sustained blockade of dopamine D2 receptor estimated from antipsychotic plasma levels in the maintenance treatment of schizophrenia: A single-blind, randomized, controlled study
- (2015) Takashi Tsuboi et al. SCHIZOPHRENIA RESEARCH
- Association of IQ Changes and Progressive Brain Changes in Patients With Schizophrenia
- (2015) Manabu Kubota et al. JAMA Psychiatry
- Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia
- (2015) Ariel Graff-Guerrero et al. JAMA Psychiatry
- A Multimodal Analysis of Antipsychotic Effects on Brain Structure and Function in First-Episode Schizophrenia
- (2015) Tyler A. Lesh et al. JAMA Psychiatry
- Should cognitive impairment be included in the diagnostic criteria for schizophrenia?
- (2015) RICHARD S.E. KEEFE World Psychiatry
- Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia
- (2014) Hiroyoshi Takeuchi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Dose and Dosing Frequency of Long-Acting Injectable Antipsychotics
- (2014) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Reappraising the long-term course and outcome of psychotic disorders: the AESOP-10 study
- (2014) C. Morgan et al. PSYCHOLOGICAL MEDICINE
- Therapeutic Window for Striatal Dopamine D2/3 Receptor Occupancy in Older Patients with Schizophrenia: A Pilot PET Study
- (2013) Hiroyuki Uchida et al. AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
- Estimated Dopamine D2 Receptor Occupancy and Remission in Schizophrenia
- (2013) Sho Moriguchi et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Progressive brain changes in schizophrenia related to antipsychotic treatment? A meta-analysis of longitudinal MRI studies
- (2013) P. Fusar-Poli et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Intermittent Drug Techniques for Schizophrenia
- (2013) S. Sampson et al. SCHIZOPHRENIA BULLETIN
- Effects of Risperidone and Olanzapine Dose Reduction on Cognitive Function in Stable Patients With Schizophrenia: An Open-Label, Randomized, Controlled, Pilot Study
- (2013) H. Takeuchi et al. SCHIZOPHRENIA BULLETIN
- Predictors of recovery in first episode psychosis: The OPUS cohort at 10year follow-up
- (2013) Stephen F. Austin et al. SCHIZOPHRENIA RESEARCH
- Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy
- (2013) Lex Wunderink et al. JAMA Psychiatry
- Antipsychotic Medication During the Critical Period Following Remission From First-Episode Psychosis
- (2013) Patrick McGorry et al. JAMA Psychiatry
- Symptom Recurrence Following Intermittent Treatment in First-Episode Schizophrenia Successfully Treated for 2 Years
- (2012) Robin Emsley et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Cross-Sectional Study of Plasma Risperidone Levels With Risperidone Long-Acting Injectable
- (2012) Saeko Ikai et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predicting relapse after a first episode of non-affective psychosis: A three-year follow-up study
- (2012) Olalla Caseiro et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis
- (2012) Stefan Leucht et al. LANCET
- Dopamine D2 receptor occupancy with risperidone or olanzapine during maintenance treatment of schizophrenia: A cross-sectional study
- (2012) Yuya Mizuno et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study
- (2012) M. Harrow et al. PSYCHOLOGICAL MEDICINE
- Brain Volumes in Schizophrenia: A Meta-Analysis in Over 18 000 Subjects
- (2012) Sander V. Haijma et al. SCHIZOPHRENIA BULLETIN
- Treatment response after relapse in a placebo-controlled maintenance trial in schizophrenia
- (2012) Robin Emsley et al. SCHIZOPHRENIA RESEARCH
- Risk factors for relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longitudinal studies
- (2012) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- The concurrent and predictive validity of symptomatic remission criteria in first-episode schizophrenia
- (2012) Wing Chung Chang et al. SCHIZOPHRENIA RESEARCH
- Early detection, early symptom progression and symptomatic remission after ten years in a first episode of psychosis study
- (2012) Wenche ten Velden Hegelstad et al. SCHIZOPHRENIA RESEARCH
- Long-term Antipsychotic Treatment and Brain Volumes
- (2011) Beng-Choon Ho et al. ARCHIVES OF GENERAL PSYCHIATRY
- How long to wait before reducing antipsychotic dosage in stabilized patients with schizophrenia? A retrospective chart review
- (2011) Hiroyoshi Takeuchi et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Evidence-based guidelines for the pharmacological treatment of schizophrenia: recommendations from the British Association for Psychopharmacology
- (2011) Thomas RE Barnes et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Antipsychotic treatment for schizophrenia in the maintenance phase: A systematic review of the guidelines and algorithms
- (2011) Hiroyoshi Takeuchi et al. SCHIZOPHRENIA RESEARCH
- Intermittent aripiprazole for schizophrenia
- (2011) Kathryn Brotzge et al. SCHIZOPHRENIA RESEARCH
- “Extended” Antipsychotic Dosing in the Maintenance Treatment of Schizophrenia
- (2010) Gary Remington et al. JOURNAL OF CLINICAL PSYCHIATRY
- Relapse Prevention in First-Episode Schizophrenia—Maintenance vs Intermittent Drug Treatment With Prodrome-Based Early Intervention
- (2010) Wolfgang Gaebel et al. JOURNAL OF CLINICAL PSYCHIATRY
- Prediction of a single psychotic episode: A 7.5-year, prospective study in first-episode psychosis
- (2010) M. Alvarez-Jimenez et al. SCHIZOPHRENIA RESEARCH
- Clinical guideline recommendations for antipsychotic long-acting injections
- (2009) John M. Kane et al. BRITISH JOURNAL OF PSYCHIATRY
- Monthly Administration of Long-Acting Injectable Risperidone and Striatal Dopamine D2 Receptor Occupancy for the Management of Schizophrenia
- (2009) Hiroyuki Uchida et al. JOURNAL OF CLINICAL PSYCHIATRY
- Predictors of Treatment Discontinuation and Medication Nonadherence in Patients Recovering From a First Episode of Schizophrenia, Schizophreniform Disorder, or Schizoaffective Disorder
- (2009) Diana O. Perkins et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started